HemaSphere (Aug 2023)
P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD3 T-CELL ENGAGER, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LATEST RESULTS FROM A PHASE 1 FIRST-IN-HUMAN CLINICAL STUDY
- Sandy W. Wong,
- Noffar Bar,
- María Victoria Mateos,
- Paz Ribas,
- Markus Hansson,
- Laura Paris,
- Craig Hofmeister,
- Paula Rodriguez-Otero,
- Maria Aranzazu Bermúdez,
- Armando Santoro,
- Andrew J. Yee,
- Maria Creignou,
- Cristina Encinas,
- Claudio Cerchione,
- Javier de la Rubia,
- Albert Oriol,
- Barbara Ferstl,
- Britta Besemer,
- Jinjie Chen,
- Alexander Chung,
- Isaac W. Boss,
- Allison Gaudy,
- Shaoyi LI,
- Kevin Hsu,
- Colin Godwin,
- Michael R. Burgess,
- Jesús San-Miguel,
- Luciano Jose Costa
Affiliations
- Sandy W. Wong
- 1 University of California San Francisco, San Francisco, United States
- Noffar Bar
- 2 Yale University School of Medicine, New Haven, United States
- María Victoria Mateos
- 3 University Hospital of Salamanca, Salamanca, Spain
- Paz Ribas
- 4 Hospital Universitario Dr Peset Aleixandre, Valencia, Spain
- Markus Hansson
- 5 Skane University Hospital, Lund, Sweden
- Laura Paris
- 7 ASST Papa Giovanni XXIII, Bergamo, Italy
- Craig Hofmeister
- 8 Winship Cancer Institute of Emory University, Atlanta, United States
- Paula Rodriguez-Otero
- 9 Clínica Universidad de Navarra, Pamplona, Spain
- Maria Aranzazu Bermúdez
- 10 Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
- Armando Santoro
- 11 Humanitas University, Pieve Emanuele, Milan, Italy
- Andrew J. Yee
- 13 Massachusetts General Cancer Center, Boston, United States
- Maria Creignou
- 14 Phase 1 unit, Center for Clinical Cancer Studies, Karolinska University Hospital, Stockholm, Sweden
- Cristina Encinas
- 15 Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain
- Claudio Cerchione
- 16 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
- Javier de la Rubia
- 17 University Hospital La Fe, Valencia, Spain
- Albert Oriol
- 18 Institut Josep Carreras and Institut Catala d’Oncologia, Hospital Germans Trias I Pujol, Barcelona, Spain
- Barbara Ferstl
- 19 Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
- Britta Besemer
- 20 University Hospital of Tuebingen, Tuebingen, Germany
- Jinjie Chen
- 21 Bristol Myers Squibb, Princeton, United States
- Alexander Chung
- 21 Bristol Myers Squibb, Princeton, United States
- Isaac W. Boss
- 21 Bristol Myers Squibb, Princeton, United States
- Allison Gaudy
- 21 Bristol Myers Squibb, Princeton, United States
- Shaoyi LI
- 21 Bristol Myers Squibb, Princeton, United States
- Kevin Hsu
- 21 Bristol Myers Squibb, Princeton, United States
- Colin Godwin
- 21 Bristol Myers Squibb, Princeton, United States
- Michael R. Burgess
- 21 Bristol Myers Squibb, Princeton, United States
- Jesús San-Miguel
- 9 Clínica Universidad de Navarra, Pamplona, Spain
- Luciano Jose Costa
- 22 University of Alabama at Birmingham, Birmingham, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000970436.12207.45
- Journal volume & issue
-
Vol. 7
p. e1220745
Abstract
No abstracts available.